Clario

Clario handles the most critical information in a clinical trial – the ‘endpoint’ data, which is the data on which decisions are taken as to whether to approve or reject a new pharmaceutical product. With expert collection of data, in house medical expertise and innovative technology solutions, Clario ensures better and faster outcomes from clinical trials.

Combining medical expertise in imaging, with expert collection of data, Clario ensures better and faster outcomes from clinical trials. Patients worldwide are now benefiting from this increased efficiency and innovation, and in turn Clario is laying strong foundations for the future. We’ve combined our business expertise with Clario’s strategic insight and focus to help shape new investment opportunities and accelerate growth. With our support Clario has invested in new technology, new services and strengthened its management team. It now serves more than 400 pharmaceutical, biotechnology and medical device clients in Europe, the US and Asia.